This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n12http://linked.opendata.cz/resource/drugbank/drug/DB07187/identifier/chemspider/
n6http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n11http://linked.opendata.cz/resource/drugbank/drug/DB07187/identifier/pdb/
n8http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n13http://linked.opendata.cz/resource/drugbank/drug/DB07187/identifier/pubchem-compound/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n14http://linked.opendata.cz/resource/drugbank/drug/DB07187/identifier/pubchem-substance/
xsdhhttp://www.w3.org/2001/XMLSchema#
n10http://linked.opendata.cz/resource/drugbank/drug/DB07187/identifier/drugbank/

Statements

Subject Item
n2:DB07187
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB07187 n8:DB07187
dcterms:title
6-[(5-CHLORO-3-METHYL-1-BENZOFURAN-2-YL)SULFONYL]PYRIDAZIN-3(2H)-ONE
adms:identifier
n10:DB07187 n11:62P n12:4925683 n13:6420118 n14:99443658
n3:IUPAC-Name
n4:271B5285-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B528B-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B528A-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5287-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5288-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5289-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5283-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B5281-363D-11E5-9242-09173F13E4C5 n4:271B5284-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5282-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5291-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5292-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B528C-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B528D-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B528F-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B528E-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5290-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B5297-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5299-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B529A-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5296-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5295-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5298-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5286-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B5293-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5294-363D-11E5-9242-09173F13E4C5